Olgu Sunumu
BibTex RIS Kaynak Göster
Yıl 2019, , 81 - 84, 03.08.2019
https://doi.org/10.33713/egetbd.521858

Öz

Kaynakça

  • 1. Cizza G, Ronsaville DS, Kleitz H, Eskandari F, Mistry S, Torvik S, et al. Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: The power study. PLoS One. 2012; 7(1): e28912. 2. Musil R, Seemüller F, Meyer S, Spellmann I, Adli M, Bauer M, et al. Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder. Int J Methods Psychiatr Res. 2018;27: e1569. 3. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med. 2004 Oct;34(7):1299-308.
  • 4. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. Am J Psychiatry. 2008; 165(3):342-51. 5. World Health Organization. ICD-11 Beta Draft. World Heal Organ. 2018. 6. Gili M, Roca M, Armengol S, Asensio D, Garcia-Campayo J, Parker G. Clinical Patterns and Treatment Outcome in Patients with Melancholic, Atypical and Non-Melancholic Depressions. PLoS One. 2012;7(10):1–8. 7. Zaki NFW, Spence DW, BaHammam AS, Pandi-Perumal SR, Cardinali DP, Brown GM. Chronobiological theories of mood disorder. European Archives of Psychiatry and Clinical Neuroscience. 2018; 268(2):107-118.
  • 8. Simpson W, Frey BN, Steiner M. Mild Depressive Symptoms During the Third Trimester of Pregnancy Are Associated with Disruptions in Daily Rhythms but Not Subjective Sleep Quality. J Women’s Heal. 2016; 25(6):594-8.
  • 9. Fletcher K, Parker G, Paterson A, Fava M, Iosifescu D, Pizzagalli DA. Anhedonia in melancholic and non-melancholic depressive disorders. J Affect Disord. 2015; 15;184:81-8. 10. Robillard R, Carpenter JS, Rogers NL, Fares S, Grierson AB, Hermens DF, et al. Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders. Transl Psychiatry. 2018; 9;8(1):213. 11. Thomas J, Khanam R, Vohora D. Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway. Neurochem Int. 2016; 99:103-109. 12. Chernova E V., Kozhechkina O V., Ter-Israelyan AY, Medvedev VE. Agomelatine (Valdoxan) in treatment of endogenous depression in day patient department. Zhurnal Nevrol i Psihiatr Im SS Korsakova. 2016; 116(10):43-46.

Melankolik Depresyon tedavisinde venlafaksin ve agomelatinin birlikte kullanımı: Bir olgu sunumu

Yıl 2019, , 81 - 84, 03.08.2019
https://doi.org/10.33713/egetbd.521858

Öz

Major Depresif Bozukluk (MDB); yaşam boyu yaygın olarak görülmektedir. Klinik depresyonun bu geniş heterojenliği, depresif alt tipleri tanımlamaya yönelik çalışmaları artırdı. Daha önceki çalışmalara göre melankolik depresyon; biyolojik bir etiyolojisi olan, çevresel olaylara tepkisiz seyreden, psikoterapiye değil somatik tedavilere cevap veren, kişilik patolojisi olmayan bireylerde daha çok görülen ve özel bir vejetatif belirti kalıbıyla (sabahları daha kötü olma, sabahları erken uyanma [rutin uyanma saatinden en az iki saat önce kalkma], belirgin psikomotor yavaşlama veya ajitasyon, belirgin iştahsızlık, kilo kaybı, aşırı veya uygunsuz suçluluk) seyreden bir depresyon tipidir. Bu nedenle bazı yazarlar melankolik depresyonun farklı psikopatolojisi, biyolojisi ve tedaviye yanıtları olması nedeniyle farklı yaklaşımlar önermişlerdir. Biz bu çalışmada major depresif bozukluk (melankoli özellikleri gösteren) tanısı koyulan 38 yaşında, kadın hastayı literatür bulguları ışığında sunmayı amaçladık. 

Kaynakça

  • 1. Cizza G, Ronsaville DS, Kleitz H, Eskandari F, Mistry S, Torvik S, et al. Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: The power study. PLoS One. 2012; 7(1): e28912. 2. Musil R, Seemüller F, Meyer S, Spellmann I, Adli M, Bauer M, et al. Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder. Int J Methods Psychiatr Res. 2018;27: e1569. 3. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med. 2004 Oct;34(7):1299-308.
  • 4. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. Am J Psychiatry. 2008; 165(3):342-51. 5. World Health Organization. ICD-11 Beta Draft. World Heal Organ. 2018. 6. Gili M, Roca M, Armengol S, Asensio D, Garcia-Campayo J, Parker G. Clinical Patterns and Treatment Outcome in Patients with Melancholic, Atypical and Non-Melancholic Depressions. PLoS One. 2012;7(10):1–8. 7. Zaki NFW, Spence DW, BaHammam AS, Pandi-Perumal SR, Cardinali DP, Brown GM. Chronobiological theories of mood disorder. European Archives of Psychiatry and Clinical Neuroscience. 2018; 268(2):107-118.
  • 8. Simpson W, Frey BN, Steiner M. Mild Depressive Symptoms During the Third Trimester of Pregnancy Are Associated with Disruptions in Daily Rhythms but Not Subjective Sleep Quality. J Women’s Heal. 2016; 25(6):594-8.
  • 9. Fletcher K, Parker G, Paterson A, Fava M, Iosifescu D, Pizzagalli DA. Anhedonia in melancholic and non-melancholic depressive disorders. J Affect Disord. 2015; 15;184:81-8. 10. Robillard R, Carpenter JS, Rogers NL, Fares S, Grierson AB, Hermens DF, et al. Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders. Transl Psychiatry. 2018; 9;8(1):213. 11. Thomas J, Khanam R, Vohora D. Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway. Neurochem Int. 2016; 99:103-109. 12. Chernova E V., Kozhechkina O V., Ter-Israelyan AY, Medvedev VE. Agomelatine (Valdoxan) in treatment of endogenous depression in day patient department. Zhurnal Nevrol i Psihiatr Im SS Korsakova. 2016; 116(10):43-46.
Toplam 4 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular İç Hastalıkları
Bölüm Olgu Sunumu
Yazarlar

Burak Okumuş 0000-0003-3591-6927

Çiçek Hocaoğlu 0000-0001-6613-4317

Yayımlanma Tarihi 3 Ağustos 2019
Kabul Tarihi 15 Mayıs 2019
Yayımlandığı Sayı Yıl 2019

Kaynak Göster

EndNote Okumuş B, Hocaoğlu Ç (01 Ağustos 2019) Melankolik Depresyon tedavisinde venlafaksin ve agomelatinin birlikte kullanımı: Bir olgu sunumu. Ege Tıp Bilimleri Dergisi 2 2 81–84.

Creative Commons Lisansı


Bu eser Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.


13425                13428            13426            13433            13427